GB2555584A

GB2555584A - Multi-layered wound dressing and method of manufacture

Info

Publication number: GB2555584A
Application number: GB1618298.2A
Authority: GB
Inventors: Patrick Neil; Sidebottom Hannah; Steward Daniel; Cole Emma
Original assignee: Smith and Nephew PLC
Current assignee: Smith and Nephew PLC
Priority date: 2016-10-28
Filing date: 2016-10-28
Publication date: 2018-05-09
Anticipated expiration: 2036-10-28
Also published as: GB2555584B; GB201618298D0; US11559437B2; CN109890339A; EP3531997B1; US20190274889A1; WO2018077872A1; EP3531997A1

Abstract

A multi-layered wound dressing comprising: a fibrous absorbent layer for absorbing exudate from a wound; and a support layer configured to reduce shrinkage of at least a portion of the wound dressing. The dressing may have a liquid impermeable film layer. The support layer may comprise a net 200 that may comprise a structure 204 having a plurality of geometric apertures 202. The structure may comprise a plurality of evenly spaced bosses 206 joined by polymer strands 208 forming geometric 202 apertures. The support layer may be located directly adjacent the absorbent layer and the support layer may comprise a bonding layer where the support layer is heat laminated to the absorbent layer fibres via the bonding layer. The dressing may further comprise a wound contact layer adjacent the absorbent layer and the dressing may also include a fluid transport layer between the wound contact layer and the absorbent layer. Also a negative pressure wound therapy kit comprising a multi-layered wound dressing and a negative pressure source in fluid connection with the dressing. Also a method of manufacturing a multi-layer wound dressing comprising the lamination of an absorbent layer with a support layer configured to reduce shrinking of the dressing.

Description

(54) Title of the Invention: Multi-layered wound dressing and method of manufacture

Abstract Title: Multi-layered wound dressing, method of manufacture and negative pressure wound therapy.

(57) A multi-layered wound dressing comprising: a fibrous absorbent layer for absorbing exudate from a wound; and a support layer configured to reduce shrinkage of at least a portion of the wound dressing. The dressing may have a liquid impermeable film layer. The support layer may comprise a net 200 that may comprise a structure 204 having a plurality of geometric apertures 202. The structure may comprise a plurality of evenly spaced bosses 206 joined by polymer strands 208 forming geometric 202 apertures. The support layer may be located directly adjacent the absorbent layer and the support layer may comprise a bonding layer where the support layer is heat laminated to the absorbent layer fibres via the bonding layer. The dressing may further comprise a wound contact layer adjacent the absorbent layer and the dressing may also include a fluid transport layer between the wound contact layer and the absorbent layer. Also a negative pressure wound therapy kit comprising a multi-layered wound dressing and a negative pressure source in fluid connection with the dressing. Also a method of manufacturing a multi-layer wound dressing comprising the lamination of an absorbent layer with a support layer configured to reduce shrinking of the dressing.

202

204

200

206

202

206

Fig. 2

1/5

108

Fig. 1

200

202

204

206

206

202

Fig. 2

2/5

Fig. 3B

3/5

Fig. 4

401

402

403

404

405

406

407

408

4/5

Fig. 5

620

Fig. 6

5/5

700

Fig. 7

MULTI-LAYERED WOUND DRESSING AND METHOD OF MANUFACTURE

The present invention relates to a multi-layered wound dressing and a method of manufacturing such a wound dressing. In particular, but not exclusively, embodiments of the present invention relate to a multi-layered wound dressing having a fibrous absorbent layer that can resist shrinkage even under extreme sterilisation methods and storage conditions, have improved aesthetics and mechanical strength and thereby increase consistency of product over its shelf life.

Wound dressings can be formed with a liquid-impermeable top layer (outer layer, furthest from the wound), which prevents wound exudates striking through and leaking from the dressing. The top layer is often also gas permeable and liquid vapour permeable, to help minimise maceration to the wound.

In some known wound dressings, the liquid-impermeable top layer can be susceptible to wrinkling (wrinkling includes but is not limited to inconsistent appearance, crinkles, creases textured surface). Wrinkling may occur whilst the wound dressing is packaged in a sterile packaging, and may be due to shrinking of one or more wound dressing layers over time. This may be due to the type of packaging and sterilisation method chosen. It could be perceived by a medical practitioner that if wrinkling is present the product has been compromised. Thus, it may not be possible to determine whether the wound dressing is still suitable for use. Wrinkling of the top layer may also occur whilst the wound dressing is in use. A wrinkled wound dressing is also visually unappealing to a patient.

Wound dressings often require a product shelf life of as long as possible, typically 5 years, so it is desirable to produce a wound dressing in which the liquid impermeable top layer is not as likely to wrinkle, become inconsistent in appearance or change aesthetics over time.

EP 1,314,410 discloses a multi-layered wound dressing having top film layer, but does not disclose any way of reducing or preventing shrinkage or wrinkling of the dressing.

According to a first aspect of the present invention there is provided a multi-layered wound dressing comprising:

a fibrous absorbent layer for absorbing exudate from a wound site; and a support layer configured to reduce shrinkage of at least a portion of the wound dressing.

According to a second aspect of the present invention there is provided a method of manufacturing a multi-layered wound dressing, the method comprising:

forming a support layer;

forming a fibrous absorbent layer for absorbing exudate from a wound site; and laminating the support layer and the absorbent layer together to form the wound 10 dressing;

wherein the support layer is configured to reduce shrinkage of at least a portion of the wound dressing.

According to a third aspect of the present invention there is provided a method of treating a 15 wound comprising placing a multi-layered wound dressing according to any embodiment disclosed herein over a wound.

According to a fourth aspect of the present invention there is provided a method of providing negative pressure wound therapy to a wound, the method comprising:

placing a multi-layered wound dressing according to any embodiment disclosed herein over a wound;

forming a fluid flow path between the wound dressing and a negative pressure source; and operating the negative pressure source to provide negative pressure to the wound.

According to a fifth aspect of the present invention there is provided a method of operating a negative pressure wound system, the method comprising:

operating a negative pressure source fluidically connected to a multi-layered wound dressing according to any embodiment disclosed herein, the wound dressing configured to be positioned over a wound.

According to a sixth aspect of the present invention there is provided a negative pressure wound therapy kit comprising a multi-layered wound dressing according to any embodiment disclosed herein and a negative pressure source configured to be fluidically connected to the wound dressing

Certain embodiments of the invention provide the advantage that at least part of the wound dressing is less likely to shrink over time compared to known wound dressings.

Certain aspects of the invention provide a wound dressing in which wrinkling in a layer or layers of a wound dressing, e.g. a liquid impermeable film layer is prevented or reduced.

Embodiments of the invention are further described hereinafter with reference to the accompanying drawings, in which:

Fig. 1 is a schematic diagram of a section of an example of a wound dressing;

Fig. 2 is a schematic diagram of an example of a support layer;

Fig. 3A is a schematic diagram of a section of another example of a wound dressing;

Fig. 3B is a perspective view of the wound dressing of Fig. 3A;

Fig. 4 is a flow diagram of an example of a method of manufacturing the wound dressing of Fig. 3A;

Fig. 5 is a schematic diagram of a further example of a wound dressing; and

Fig. 6 is a schematic diagram of a yet further example of a wound dressing.

Fig. 7 is a schematic diagram of an example of a negative pressure wound therapy system.

In the drawings like reference numerals refer to like parts.

Fig. 1 shows an example of a multi-layer wound dressing 100. The wound dressing 100 includes a liquid impermeable film layer 102 located at the top of the wound dressing 100. In use, the film layer 102 is the top layer of the wound dressing 100, most distal from a wound site.

The film layer 102 is also gas and vapour permeable to allow for evaporation of fluid or wound exudate from the wound dressing 100, and help prevent maceration of the wound. In this example, the film layer 102 is formed from a polyurethane blend, though other suitable materials may include other polymeric materials, for example polyethylene, or polypropylene.

An absorbent layer 108 underlies the film layer 102. The absorbent layer 108 has a fibrous structure for absorbing exudate from a wound site. In this example, the absorbent layer 108 includes superabsorbent fibres. The absorbent layer 108 also includes other fibres. In this example, the absorbent layer includes superabsorbent fibres, viscose fibres and polyester fibres.

In this example, the absorbent layer 108 includes around 40% superabsorbent fibres, 40% viscose fibres, and 20% polyester fibres. In other examples, the absorbent layer may include around 0-50% superabsorbent fibres, 0-100% viscose fibres and 0-50% polyester fibres. Suitable superabsorbent fibres include crosslinked acrylate copolymer fibres that are partially neutralized to sodium salt however other superabsorbent fibres are available. The absorbent layer 108 may be manufactured using a needling process in which the fibres are mechanically tangled together.

In other examples, the absorbent layer may include other ratios of superabsorbent, viscose and polyester fibres. For example, the absorbent layer may include around 50% superabsorbent fibres, 35% viscose fibres and 20% polyester fibres. Alternatively, the absorbent layer may include 40% superabsorbent fibres and 60% viscose fibres.

The film layer 102 is located over the absorbent layer 108 so that wound exudate collected in the absorbent layer 108 can evaporate out of the wound dressing 100 through the film layer 102.

A support layer 106 is located between the film layer 102 and the absorbent layer 108. The support layer 106 helps to reinforce the structure of the absorbent layer 108 and thereby reduce shrinkage ofthe wound dressing 100. The support layer 102 also helps to provide extra mechanical strength to the film layer 102 to reduce or prevent wrinkling of the film layer 102 over time. The mechanical strength also reduces the chance of the dressing deforming or rolling up causing a pressure point.

Aptly, the support layer 106 is configured to have a tensile strength from 0.05 to 0.06 Nm to provide mechanical strength to the surrounding layers (e.g. the film layer 102 and the absorbent layer 108) without compromising the flexibility of the wound dressing 100. The support layer 106 may have a thickness of from 50 to 150 pm. Aptly, the support layer 106 may have a thickness of around 100 to 110 pm.

Referring to Fig. 2, the support layer 106 includes a net 200 configured to reduce shrinkage of the wound dressing 100. Aptly, the net 200 is configured to reduce shrinkage of the absorbent layer 108 and/or the film layer 102 to help reduce wrinkling of the film layer 102.

In this example, the net 200 has a substantially hexagonal (or honeycomb) structure 204 including a plurality of substantially triangular shaped apertures 202 extending therethrough.

The hexagonal structure 204 is formed from a plurality of dots (or bosses) 206 joined by polymer strands 208. The dots 206 are substantially evenly spaced with respect to each other. Each dot forms a vertex of the hexagonal pattern in the structure 204. Each dot 206 is joined to six surrounding dots 206 by polymer strands 208. That is, six polymer strands 208 extend from each dot 206 and each connect to a respective surrounding dot 206 to form the hexagonal structure 204 having triangular shaped apertures 202 between the polymer strands 208.

Each of the triangular shaped apertures 202 may have an area A of from 0.005 to 0.32 mm². This allows liquid vapour from a wound to pass freely through the apertures, whilst still providing sufficient strength to the support layer 106.

It can also be said that the structure 204 is a structure comprising a plurality of strands or struts that are joined to form a plurality of triangles. In this example the triangles tessellate in rows. It will be appreciated that the strands or struts may be arranged in other formations, for example squares, diamonds or rectangles with different geometries and therefore differing open areas.

In this example, the support layer 106 is located directly adjacent the absorbent layer 108. As such, the support layer 106 can effectively provide additional mechanical strength to fibres in the top surface of the absorbent layer 108. This can help prevent movement of the fibres and reduce shrinking of the absorbent layer 108.

Aptly, the support layer 106 is bonded to the fibres in the top surface of the absorbent layer 108. This can help to lock the fibres in position and prevent or reduce any movement. In this example, the support layer 106 further includes a bonding layer for heat laminating the net 200 to the absorbent layer 108. The support layer 106 is thus heat laminated to fibres in the absorbent layer 108 via the bonding layer.

The bonding layer contained within the net has a lower melting temperature than the net 200 so that the support layer 106 can be heat laminated to the absorbent layer 108 whilst maintaining the structure of the net 200. The bonding layer can be formed from a low melting point polymer, for example a low melting point ethylene-vinyl acetate, whilst the net 200 may be formed from a high density polyethylene, which melts at a higher temperature than the bonding layer. Other polymers having a lower melting point than the net 200 may also be suitable. For example the bonding layer may be a separate layer or alternatively include an ethylene-acrylate or thermoplastic polyurethane based adhesive.

The net 200 and the bonding layer can be coextruded to form the support layer 106. Aptly, the bonding layer is extruded with a similar structural shape to the net 200, so that the apertures 202 in the net 200 are not obstructed by the bonding layer. This helps to ensure that exudate the absorbent layer 108 can pass through the support layer and evaporate out of the wound dressing 100 through the film layer 102.

Fig. 3 illustrates another example of a multi-layered wound dressing 300. The wound dressing 300 includes a film layer 302, support layer 306 and absorbent layer 308, the same as the film layer 102, support layer 106 and absorbent layer 108 described in relation to Fig. 1.

The wound dressing 300 also includes a first adhesive layer 304, located between the film layer 302 and the support layer 306, for attaching the film layer 302 to the support layer 306. The first adhesive layer 304 is a hot melt adhesive applied to a wound facing side (underside) of the film layer 302. Aptly, the first adhesive layer 304 is pattern coated onto the film layer 302, to include holes, so that gas and liquid vapour can pass through holes in the first adhesive layer 304. In other examples the film layer 302 may be laminated (e.g. heat laminated) directly onto the support layer 306 without the need for an adhesive layer 304 in between.

In this example, the wound dressing 300 also includes a foam layer 312, which is a fluid transport layer. The foam layer 312 is located under the absorbent layer 306. The foam layer 312 acts to draw fluid away from a wound site and transport the fluid to the absorbent layer 308. The foam layer may be formed from an open cell polyurethane foam and other options are available, as will be recognised by those skilled in the art.

An adhesive web layer 310 is located between the foam layer 312 and the absorbent layer 108 to adhere the foam layer 312 to the absorbent layer 308. The adhesive web layer may be formed from bicomponent polypropylene/polyethylene fibres. Such bicomponent fibres are known in the art, so for brevity will not be discussed in detail. The adhesive web layer 310 includes a plurality of apertures extending therethrough to allow for passage of exudate from the foam layer 312 to the absorbent layer 108.

The wound dressing 300 also includes a wound contact layer 320, which includes a perforated film 316. The perforated film 316 is located under the foam layer 312 and helps to prevent the wound dressing 100 from attaching to the wound as the wound heals. For example, where the wound dressing 300 includes the foam layer 112, the perforated film 316 can prevent new tissue from growing into cells of the foam layer 312. In other examples, the foam layer 312 may not be present and the perforated film 316 can help prevent fibres of the absorbent layer 308 from becoming embedded in the wound. Perforations in the perforated film 316 are aptly substantially uniformly distributed and are of suitable size to allow passage of exudate into the wound dressing 300, e.g. with holes having a diameter of 1-2.5 mm. The perforated film 316 is aptly formed from polyurethane.

The wound contact layer 320 may also include an adhesive 318 located under the perforated film 316 (i.e. on the wound facing side of the perforated film 316) for adhering the wound dressing 300 to the skin. In this case the adhesive is silicone 318 and is aptly spread onto the underside of the perforated film with a coat weight of around 30-200 g/m². In some other examples, an additional attachment element, for example bandages, strips of tape, or compression bandages may be used to secure the wound dressing 300 to the patient.

The top side of the perforated film 316 (i.e. the side distal from the wound) may be coated with a further adhesive layer 314. The further adhesive layer 314 adheres the wound contact layer 320 to the foam layer 312. Aptly, the further adhesive layer 314 may be an acrylic adhesive, though other suitable adhesives may also be used. In other examples the wound contact layer 320 may be laminated (e.g. heat laminated) directly to the foam layer 312, without the need for the further adhesive layer 314 in between.

Fig. 4 illustrates an example of a method of manufacturing the wound dressing 300. The method is not limited to the steps shown and, as described above, may include additional steps. The method also is not limited to the order shown in Fig. 4. As will be appreciated by those skilled in the art, several of the method steps shown may be performed in a different order. In some embodiments, the wound dressing 300 is manufactured by forming each of the layers, and assembling the layers in the correct order, before heat laminating them together.

The film layer 302 may be formed by extrusion. At step 401, the first adhesive layer 304 is applied to the film layer. Aptly, the first adhesive layer 304 is pattern coated onto the underside of the extruded film layer 302.

At step 402 the support layer 306 and the absorbent layer 308 are heat laminated together to form a single piece. At step 403 the film layer 302 and first adhesive layer 304 are heat laminated to the support layer 306 on the top side of the single piece and the adhesive web layer 310 and foam layer 312 are heat laminated to the absorbent layer 308. Whilst the layers have been described as being heat laminated together in a specific order, the layers may be separately laminated together or laminated together all at the same time.

At step 404 the wound contact layer 320 is formed by coating one side of a film layer with the silicone adhesive layer 314, and coating the other side of the film layer with a further adhesive layer 314. The film layer is then perforated at step 405 (e.g. by needle punching), to form the wound contact layer 320 including the perforated film 316, the silicone adhesive layer 314 for contacting the wound and the further adhesive layer 314. Alternatively, the film layer may be perforated before adding the further adhesive layer 314.

The wound contact layer may then be laminated (e.g. with heat, ultrasonic and/or radio frequency welding) to the underside of the foam layer 312 to form the wound dressing 300, as shown at step 406.

At step 407 a removable cover may be applied to the underside of the silicone adhesive layer 318. This cover can be removed before the wound dressing 300 is applied to a patient.

At step 408 the wound dressing 300 may be cut into separate wound dressing pieces, each suitably sized for an intended application.

In another example, as shown in Fig. 5, the film layer 502 may have a larger surface area than the remainder of the wound dressing 500 so that it extends further outwardly than the other layers of the wound dressing. The wound-facing (underside) of the film layer may be coated with a pressure sensitive adhesive 504 (or other suitable adhesive) for sticking the dressing to the patient around the wound periphery. The pressure sensitive adhesive 504 may also adhere the film layer 502 to the support layer 506 of the wound dressing 500. The wound dressing may also include an absorbent layer 508, adhesive web layer 510, foam layer 512, further adhesive layer 514 and wound contact layer 520. Each of the layers in this example may be similar to corresponding layers described above in relation to Figs. 3A and 3B, so for brevity will not be described again in detail.

In this example, the wound dressing may be manufactured following steps 401 to 407 described above. However, instead of cutting the dressing to size (step 408) each wound dressing may be made individually with each layer cut or formed to the desired size prior to laminating all the layers together so that the final wound dressing has a film layer larger than the other layers.

In a further example, as shown in Fig. 6, both the wound contact layer 620 and the film layer 602 may extend beyond the remaining layers of the wound dressing 600. The wound contact layer 620 and the film layer may be adhered together around the periphery (e.g. via an adhesive layer 604), so that the remaining layers of the wound dressing are sandwiched between the wound contact layer 620 and the film layer 602. In other words the support layer 606, the absorbent layer 608, the adhesive web layer 610, and the foam layer 612 may be sealed within a cavity 622 between the film layer 602 and the wound contact layer 620. In this example, a further adhesive layer 614 adheres the foam layer 612 to the wound contact layer 620, though in other examples the further adhesive layer 614 may not be required. Each of the layers in this example may be similar to corresponding layers described above in relation to Figs. 3A and 3B, so for brevity will not be described again in detail.

The wound dressing 600 in this example may be manufactured similarly to the wound dressing 300, as described above, but with the film layer 602 and the wound contact layer 620 being laminated together around the periphery (e.g. via the adhesive layer 604) to sandwich the remaining layers between the film layer 602 and the wound contact layer 620. Alternatively, the film layer 602 may be directly laminated around the periphery (e.g. heat laminated) to the wound contact layer 620, without the need for the additional adhesive layer 604.

Although the wound dressings 300, 500, 600 have been described having several adhesive layers, one or more of these layers may not be present. For example, the perforated film itself may be formed from a hot melt adhesive material so that it can be directly heat laminated onto the foam layer, in which case the further adhesive layer may not be needed. In another example, the adhesive web layer may not be present if the foam and absorbent layers are adhered in another way. For example, the foam and absorbent layers may be directly chemically bonded together. Similarly, the first adhesive layer may not be needed. For example if the support layer includes an adhesive material, or if the film layer itself is formed from a hot melt adhesive then the film layer and the support layer may be directly adhered together.

In another example, the wound dressing may be provided without the foam layer. The foam layer helps to transport exudate away from the wound. However in some cases, and depending on the severity of a wound, the absorbent layer may sufficiently draw exudate from the wound without the need for the foam layer.

Although in the examples described above, the support layer is heat laminated to the absorbent layer via a bonding layer, other laminating techniques may be suitable. For example, the bonding layer may include a pressure sensitive adhesive. In this case, heat may not be required to laminate the support layer and adhesive layer together.

Although in the example described above, the net layer has been described as having a substantially hexagonal shaped structure, other geometric structures may also be suitable. With other geometric structures, the apertures may also have different geometric shapes.

In another example, the wound dressing may include more than one support layer to provide support to other layers in the wound dressing. For example a first support layer may be located between the liquid impermeable film layer and the absorbent layer, and a further support layer may be located between the absorbent layer and the fluid transport layer (foam layer). This may help to support the absorbent layer from both sides to further reduce shrinking of the absorbent layer.

Any of the examples described herein may be adapted for use with a negative pressure system (sometimes referred to as a reduced pressure system) including a source of negative pressure, such as a negative pressure pump. For example, the film layer may include a negative pressure interface, such as a port, to which a negative pressure supply tube may be connected. The supply tube may be connected to a negative pressure source so that, in use, the negative pressure source applies a negative pressure to the wound dressing between the film layer and the wound to help draw wound exudate away from the wound and into the absorbent layer of the dressing.

Fig. 7 illustrates an example of a negative pressure wound therapy system 700. The system includes a wound cavity 710 covered by a wound dressing 720, which can be a dressing according to any of the examples described herein. The dressing 720 can be positioned inside the wound cavity 710 and further seal the wound cavity so that negative pressure can be maintained in the wound cavity. For example, a film layer of the wound dressing 720 can provide substantially fluid impermeable seal over the wound cavity 710. A single or multi lumen tube or conduit 740 connects the wound dressing 720 with a negative pressure device 750 configured to supply reduced pressure. The negative pressure device 750 includes a negative pressure source. The negative pressure device 750 can be a canisterless device (meaning that exudate is collected in the wound dressing and/or is transferred via the tube 740 for collection to another location). In some embodiments, the negative pressure device 750 can be configured to include or support a canister. Additionally, in any of the embodiments disclosed herein, the negative pressure device 750 can be fully or partially embedded in, mounted to, or supported by the wound dressing 720.

The conduit 740 can be any suitable article configured to provide at least a substantially sealed fluid flow path or pathway between the negative pressure device 750 and the wound cavity 710 so as to supply reduced pressure to the wound cavity. The conduit 740 can be formed from polyurethane, PVC, nylon, polyethylene, silicone, or any other suitable rigid or flexible material. In some embodiments, the wound dressing 720 can have a port configured to receive an end of the conduit 740. For example, a port can include a hole in the film layer. In some embodiments, the conduit 740 can otherwise pass through and/or under a film layer of the wound dressing 720 to supply reduced pressure to the wound cavity 710 so as to maintain a desired level of reduced pressure in the wound cavity. In some embodiments, at least a part of the conduit 740 is integral with or attached to the wound dressing 720.

In use, the wound dressing, such as the wound dressing 100, 300, 500, or 600, is applied to a wound site with the wound contact layer 320 contacting the wound. Exudate from the wound may pass through the perforated film 116 and into the foam layer 312, which acts to transport wound exudate away from the wound into the absorbent layer 308. Wound exudate collected in the absorbent layer 308 can evaporate from the wound dressing 300 through the vapour permeable film layer 302.

The support layer helps to provide mechanical strength to the absorbent layer, which may swell when it is wet and may shrink as it dries. The support layer can help to minimise movement of fibres in the absorbent layer at least on the side distal from the wound and thus helps to prevent shrinking of the wound dressing, particularly in this region. Minimising shrinking of the wound dressing in this way can in turn can help to prevent wrinkling of the film layer. It also reduced the chance of the dressing rolling/folding up under secondary retention.

As the wound dressing becomes exposed to moisture (either from the wound or the surrounding atmosphere), it may swell or expand causing increased wrinkling of the film layer. Having the support layer adhered to the film layer can help to provide support to the film layer and resist wrinkling of the film layer by providing additional mechanical strength to the film layer.

The above described wound dressings are less likely to exhibit shrinking whilst stored in sterile packaging than previously known wound dressings. Thus, wrinkling of the film layer on the outside of the wound dressing can be prevented or reduced. A medical practitioner is therefore less likely to disregard a wound dressing that is still within its recommended shelf life, sterile and suitable for use, purely because of visual appearance of the film layer.

The hexagonal and/or triangular shape of the net structure of the support layer helps to provide mechanical strength and can be particularly effective at resisting against shrinkage of surrounding wound dressing layers.

Throughout the description and claims of this specification, the words “comprise” and “contain” and variations of them mean “including but not limited to”, and they are not intended to (and do not) exclude other moieties, additives, components, integers or steps. Throughout the description and claims of this specification, the singular encompasses the plural unless the context otherwise requires. In particular, where the indefinite article is used, the specification is to be understood as contemplating plurality as well as singularity, unless the context requires otherwise.

Features, integers, characteristics, compounds, chemical moieties or groups described in conjunction with a particular aspect, embodiment or example of the invention are to be understood to be applicable to any other aspect, embodiment or example described herein unless incompatible therewith. All of the features disclosed in this specification (including any accompanying claims, abstract and drawings), and/or all of the steps of any method or process so disclosed, may be combined in any combination, except combinations where at least some of such features and/or steps are mutually exclusive. The invention is not restricted to the details of any foregoing embodiments. The invention extends to any novel one, or any novel combination, of the features disclosed in this specification (including any accompanying claims, abstract and drawings), or to any novel one, or any novel combination, of the steps of any method or process so disclosed.

The reader's attention is directed to all papers and documents which are filed concurrently with or previous to this specification in connection with this application and which are open to public inspection with this specification, and the contents of all such papers and documents are incorporated herein by reference.

Claims

1. A multi-layered wound dressing comprising:

a fibrous absorbent layer for absorbing exudate from a wound site; and

5 a support layer configured to reduce shrinkage of at least a portion of the wound dressing.

2. A multi-layered wound dressing according to claim 1, further comprising a liquid impermeable film layer, wherein the support layer is located between the absorbent layer

10 and the film layer.

3. A multi-layered wound dressing according to claim 1 or 2, wherein the support layer comprises a net.

15

4. A multi-layered wound dressing according to claim 3, wherein the net comprises a geometric structure having a plurality of substantially geometric apertures extending therethrough.

5. A multi-layered wound dressing according to claim 4, wherein the geometric structure

20 comprises a plurality of bosses substantially evenly spaced and joined by polymer strands to form the substantially geometric apertures between the polymer strands.

6. A multi-layered wound dressing according to claim 4 or 5, wherein the apertures have an area from 0.005 to 0.32 mm2.

7. A multi-layered wound dressing according any preceding claim, wherein the support layer has a tensile strength from 0.05 to 0.06 Nm.

8. A multi-layered wound dressing according to any preceding claim, wherein the support layer has a thickness of from 50 to 150 pm.

9. A multi-layered wound dressing according to any preceding claim, wherein the support

5 layer is located directly adjacent the absorbent layer.

10. A multi-layered wound dressing according to any preceding claim, wherein the support layer is bonded to fibres in a top surface of the absorbent layer.

10

11. A multi-layered wound dressing according to claim 10, wherein the support layer further comprises a bonding layer, wherein the support layer is heat laminated to the fibres in the absorbent layer via the bonding layer.

12. A multi-layered wound dressing according to claim 11, wherein the bonding layer

15 comprises a low melting point ethylene-vinyl acetate adhesive.

13. A multi-layered wound dressing according to any preceding claim, wherein the net is formed from high density polyethylene.

20

14. A multi-layered wound dressing according any of claims 2 to 13 claim, further comprising an adhesive layer attaching the film layer to the support layer.

15. A multi-layered wound dressing according to any preceding claim, further comprising a wound contact layer located adjacent the absorbent layer for positioning adjacent a wound.

16. A multi-layered wound dressing according claim 15, further comprising a fluid transport layer between the wound contact layer and the absorbent layer for transporting exudate away from a wound into the absorbent layer.

17. A method of treating a wound comprising placing a multi-layered wound dressing according to any preceding claim over a wound.

5

18. A method of providing negative pressure wound therapy to a wound, the method comprising:

placing a multi-layered wound dressing according to any of claims 1 to 16 over a wound;

forming a fluid flow path between the wound dressing and a negative pressure 10 source; and operating the negative pressure source to provide negative pressure to the wound.

19. A method of operating a negative pressure wound system, the method comprising:

operating a negative pressure source fluidically connected to a multi-layered wound 15 dressing according to any of claims 1 to 16, the wound dressing configured to be positioned over a wound.

20. A negative pressure wound therapy kit comprising a multi-layered wound dressing according to any of claims 1 to 16 and a negative pressure source configured to be

20 fluidically connected to the wound dressing.

21. A method of manufacturing a multi-layered wound dressing, the method comprising:

forming a support layer;

forming a fibrous absorbent layer for absorbing exudate from a wound site; and

25 laminating the support layer and the absorbent layer together to form the wound dressing;

Intellectual

Property

Office

Application No: GB1618298.2 Examiner: Colin Powys